Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Toobit Launches USDC Trial Funds for Risk-Free Futures Trading
-
Ontario Details Major Niagara Investment in Exclusive Interview on My Generation, with Host Sam Miele
-
Fortuna reports progress on its share buyback program
-
ADI Foundation Partners with M-Pesa to Bring 60+ Million Mobile Money Platform Users Onchain
-
Karolinska Development’s Extraordinary General Meeting 2026
-
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
-
Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort
-
Bitget TradFi Surpasses $2 Billion in Daily Volume as Gold Trading Activity Surges
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Toobit Upgrades Trading Experience with New Suite of Trading Features and Safety Updates
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE S&P 500 VIX SHORT-TERM FUTURES 2.25X DAILY LEVERAGED SECURITIES ISIN:
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
21Shares AG: Publication of UK Base Prospectus
-
B2PRIME Integrates with TradingView and Becomes Its Platinum Partner to Deliver Seamless Charting and Trade Execution
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
MICHAEL SCHUMACHER’S FIRST F1 GRAND PRIX-WINNING 1992 BENETTON B192-05 TO STAR IN BROAD ARROW’S GLOBAL ICONS: EUROPE ONLINE AUCTION
-
December 2025 Quarterly Production Update
-
Global mayors' dialogue in Harbin charts course for sustainable winter economy
-
Global mayors' dialogue in Harbin charts course for sustainable winter economy
-
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
-
Wery AI Launches All-in-One Creative Suite to Simplify Professional Content Creation
-
EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome
-
Share Buyback Transaction Details January 2 – January 7, 2026
-
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
-
NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s
-
Tarkett climate leadership recognized for the second time by a CDP A Score
-
Form 8.5 (EPT/RI)-NCC Group plc
-
UTStarcom Launches SkyFlux SPN310 to Empower Enterprise and Metro Edge Networks
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
RCI BANQUE: Issuance of EUR 900 million fixed rate notes maturing in February 2032
-
Statement from BNP Paribas - Sudan Litigation
-
New Earth Resources Announces Comprehensive Exploration Program for its SL Rare Earth Elements Project
-
PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows
-
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
-
Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis
-
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
-
VGP NV Announces the Launch of a Capped Cash Tender Offer for its Outstanding Green Bonds Due 17 January 2027 and the Intention to Concurrently Issue New Green Bonds
-
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
-
ISIN DK0030484621 - FRN Tryg Forsikring A/S Subordinated Callable SEK 1,000,000,000 Bond Issue (the "Bonds") - Exercise of Ordinary Call - Key information
-
Crédit Agricole Assurances announces the launch of a tender offer for two series of subordinated fixed rate resettable notes and its intention to issue Tier 2 subordinated notes
-
Quadient Achieves A- Rating from CDP, Marking a Major Milestone in Its ‘Elevate to 2030’ Climate Ambition
-
SOITEC BOARD OF DIRECTORS APPOINTS LAURENT RÉMONT CHIEF EXECUTIVE OFFICER, EFFECTIVE APRIL 2026
-
Director Declaration
-
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
-
Regarding the appointment of an independent member to the EPSO-G Nomination and Remuneration Committee
-
Luminor provides EUR 17 million in financing for four commercial projects developed by companies managed by AB Tewox
-
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
-
Gold Production for YE 2025 and Award of Impact Benefit Agreement (“IBA”)
-
Shell fourth quarter 2025 update note
-
Gold Production for YE 2025 and Award of Impact Benefit Agreement (“IBA”)
